An interpretable machine learning scoring tool for estimating time to recurrence readmissions in stroke patients.

Abstract

Background: Stroke recurrence readmission poses an additional burden on both patients and healthcare systems. Risk stratification aims to accurately divide patients into groups to provide targeted interventions at reducing readmission. To accurately predict short and intermediate-term risks of readmission and provide information for further temporal risk stratification, we developed and validated an interpretable machine learning risk scoring tool.

Methods: In this retrospective study, all stroke admission episodes from January 1st 2015 to December 31st 2019 were obtained from the Shanghai Health and Health Development Research Centre database, which covers medical records of all patients hospitalized in 436 medical institutes in Shanghai. The outcome was time to stroke recurrence readmission within 90 days post discharge. The Score for Stroke Recurrence Readmission Prediction (SSRRP) tool was derived via an interpretable machine learning-based system for time-to-event outcomes. SSRRP as six-variable survival score includes sequelae, length of stay, type of stroke, random plasma glucose, medical expense payment, and number of hospitalizations.

Results: A total of 339,212 S admission episodes were finally included in the whole cohort. Among them, 217,393 episodes were included in the training dataset, 54,347 episodes in the internal validation dataset, and 67,472 in the temporal validation dataset. Readmission within 90 days was documented in 33922(9.97 %) episodes, with a median time to emergency readmission of 19 days (Interquartile range: 8-43). In the temporal validation dataset, the SSRRP achieved an integrated area under the curve of 0.730(95 % CI, 0.724-0.737). In addition, SSRRP demonstrated good calibration and clinical benefit rate.

Conclusions: In this retrospective cohort study, the SSRRP, a parsimonious and point-based scoring tool, was developed to predict the risk of recurrent readmission for stroke. It also provided accurate information on the time to stroke readmission, enabling further temporal risk stratification and informed clinical decision-making.